Skip to main content

. 1963 Mar;42(3):346–361. doi: 10.1172/JCI104721

IN VIVO BEHAVIOR OF I¹³¹-FIBRINOGEN

A S McFarlane ¹

PMCID: PMC289287 PMID: 16695897

346

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BRADLEY J. E., HOLLOWAY R. C., McFARLANE A. S. Assay of 14C in the gas phase as carbon dioxide. Biochem J. 1954 Jun;57(2):192–195. [PubMed] [Google Scholar]
CAMPBELL R. M., CUTHBERTSON D. P., MATTHEWS C. M., MCFARLANE A. S. Behaviour of 14C- and 131I-labelled plasma proteins in the rat. Int J Appl Radiat Isot. 1956 Jul;1(1-2):66–84. doi: 10.1016/0020-708x(56)90020-5. [DOI] [PubMed] [Google Scholar]
CHRISTENSEN L. K. The turnover of plasma fibrinogen. Acta Med Scand. 1958 Nov 27;162(5):407–414. doi: 10.1111/j.0954-6820.1958.tb01787.x. [DOI] [PubMed] [Google Scholar]
COHEN S., HOLLOWAY R. C., MATTHEWS C., MCFARLANE A. S. Distribution and elimination of 131 I- and 14C-labelled plasma proteins in the rabbit. Biochem J. 1956 Jan;62(1):143–154. doi: 10.1042/bj0620143. [DOI] [PMC free article] [PubMed] [Google Scholar]
GITLIN D., BORGES W. H. Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. Blood. 1953 Aug;8(8):679–686. [PubMed] [Google Scholar]
HAMMOND J. D., VEREL D. Observations on the distribution and biological half-life of human fibrinogen. Br J Haematol. 1959 Oct;5:431–438. doi: 10.1111/j.1365-2141.1959.tb04053.x. [DOI] [PubMed] [Google Scholar]
HELMKAMP R. W., GOODLAND R. L., BALE W. F., SPAR I. L., MUTSCHLER L. E. High specific activity iodination of gamma-globulin with iodine-131 monochloride. Cancer Res. 1960 Nov;20:1495–1500. [PubMed] [Google Scholar]
JOHNSON A., DAY E. D., PRESSMAN D. The effect of iodination on antibody activity. J Immunol. 1960 Feb;84:213–220. [PubMed] [Google Scholar]
LEWIS J. H., FERGUSON E. E., SCHOENFELD C. Studies concerning the turnover of fibrinogen I-131 in the dog. J Lab Clin Med. 1961 Aug;58:247–258. [PubMed] [Google Scholar]
LORAND L., MIDDLEBROOK W. R. Studies on fibrino-peptide. Biochim Biophys Acta. 1952 Nov;9(5):581–582. doi: 10.1016/0006-3002(52)90215-1. [DOI] [PubMed] [Google Scholar]
MATTHEWS C. M. The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol. 1957 Jul;2(1):36–53. doi: 10.1088/0031-9155/2/1/305. [DOI] [PubMed] [Google Scholar]
MCFARLANE A. S. Labelling of plasma proteins with radioactive iodine. Biochem J. 1956 Jan;62(1):135–143. doi: 10.1042/bj0620135. [DOI] [PMC free article] [PubMed] [Google Scholar]
McFARLANE A. S. Efficient trace-labelling of proteins with iodine. Nature. 1958 Jul 5;182(4627):53–53. doi: 10.1038/182053a0. [DOI] [PubMed] [Google Scholar]
McFARLANE A. S. The behavior of I 131-labeled plasma proteins in vivo. Ann N Y Acad Sci. 1957 Aug 30;70(1):19–25. doi: 10.1111/j.1749-6632.1957.tb35374.x. [DOI] [PubMed] [Google Scholar]
McFARLANE A. S. Use of labelled plasma proteins in the study of nutritional problems. Prog Biophys Biophys Chem. 1957;7:115–163. [PubMed] [Google Scholar]
RESCIGNO A. A contribution to the theory of tracer methods. II. Biochim Biophys Acta. 1956 Jul;21(1):111–116. doi: 10.1016/0006-3002(56)90100-7. [DOI] [PubMed] [Google Scholar]
STANBURY J. B., KASSENAAR A. A., MEIJER J. W. The metabolism of iodotyrosines. I. The fate of mono- and di-iodotyrosine in normal subjects and in patients with various diseases. J Clin Endocrinol Metab. 1956 Jun;16(6):735–746. doi: 10.1210/jcem-16-6-735. [DOI] [PubMed] [Google Scholar]
STERLING K. The turnover rate of serum albumin in man as measured by I131-tagged albumin. J Clin Invest. 1951 Nov;30(11):1228–1237. doi: 10.1172/JCI102542. [DOI] [PMC free article] [PubMed] [Google Scholar]
TERRES G., HUGHES W. L., WOLINS W. Whole-body measurement of radioactivity as a means of following in vivo the degradation of I-131-labeled proteins in mice. Am J Physiol. 1960 Jun;198:1355–1360. doi: 10.1152/ajplegacy.1960.198.6.1355. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES